These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30072154)

  • 1. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.
    Cardoso R; Knijnik L; Whelton SP; Rivera M; Gluckman TJ; Metkus TS; Blumenthal RS; McEvoy JW
    Int J Cardiol; 2018 Oct; 269():80-88. PubMed ID: 30072154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
    Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
    Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials.
    Verma S; Goodman SG; Mehta SR; Latter DA; Ruel M; Gupta M; Yanagawa B; Al-Omran M; Gupta N; Teoh H; Friedrich JO
    BMC Surg; 2015 Oct; 15():112. PubMed ID: 26467661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
    Nagashima Z; Tsukahara K; Uchida K; Hibi K; Karube N; Ebina T; Imoto K; Kimura K; Umemura S
    J Cardiol; 2017 Jan; 69(1):156-161. PubMed ID: 26987791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis.
    Agrawal A; Kumar A; Majid M; Badwan O; Arockiam AD; El Dahdah J; Syed AB; Schleicher M; Reed GW; Cremer PC; Griffin BP; Menon V; Wang TKM
    Heart; 2024 Feb; 110(5):323-330. PubMed ID: 37648436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.
    Wang A; Wu A; Wojdyla D; Lopes RD; Newby LK; Newman MF; Smith PK; Alexander JH
    Am Heart J; 2018 May; 199():150-155. PubMed ID: 29754654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of aspirin and clopidogrel after coronary artery bypass graft surgery.
    de Leon N; Jackevicius CA
    Ann Pharmacother; 2012 May; 46(5):678-87. PubMed ID: 22570427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass surgery: survival and safety outcomes.
    Rocha-Gomes JN; Saraiva FA; Cerqueira RJ; Moreira R; Ferreira AF; Barros AS; Amorim MJ; Pinho P; Lourenço AP; Leite-Moreira AF
    J Cardiovasc Surg (Torino); 2020 Oct; 61(5):662-672. PubMed ID: 32431135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of clopidogrel versus aspirin as a maintenance monotherapy 1 year after coronary artery bypass grafting.
    Kim JS; Kang Y; Sohn SH; Hwang HY
    Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 37039835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial.
    Benedetto U; Altman DG; Gerry S; Gray A; Lees B; Flather M; Taggart DP;
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):456-461. PubMed ID: 28387790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
    Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
    J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial.
    Rafiq S; Johansson PI; Kofoed KF; Lund JT; Olsen PS; Bentsen S; Steinbrüchel DA
    Platelets; 2017 Dec; 28(8):786-793. PubMed ID: 28277060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting.
    Ebrahimi R; Gupta S; Carr BM; Bishawi M; Bakaeen FG; Almassi GH; Collins J; Grover FL; Quin JA; Wagner TH; Shroyer ALW; Hattler B
    Am J Cardiol; 2018 Mar; 121(6):709-714. PubMed ID: 29402422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis.
    Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M
    BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.